« Previous
Next »
Research in Social and Administrative Pharmacy
Volume 5, Issue 3
, Pages 211-224
, September 2009
The impact of nonreferral outpatient co-payment on medical care utilization and expenditures in Taiwan
References
- . Does universal health insurance make health care unaffordable? Lessons from Taiwan. Health Aff. 2003;22:77–88
- . The effect of universal health insurance on health care utilization in Taiwan. Results from a natural experiment. JAMA. 1997;278:89–93
- DiPiero A. Universal problems and universal healthcare: 6 countries—6 systems, Healthcare Forum. Oregons' Future, Fall 2004, 27–31.
- . Pharmaceutical benefit scheme and cost containment in Taiwan's National Health Insurance. J Pharm Financ Econ Policy. 2004;12:133–149
- . Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly. Med Care. 2003;41:1331–1342
- . Changes in drug utilization following the outpatient prescription drug cost-sharing program—evidence from Taiwan's elderly. Health Policy. 2004;68:277–287
- . Patterns of ambulatory care utilization in Taiwan. BMC Health Serv Res. 2006;6:54
- . Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 1999–2000. Vital health Stat 13. 2004;157:1–70
- . The National Health Insurance Statistics 2001. Available at: http://www.nhi.gov.tw/english/webdata.asp?menu=11&menu_id=296&webdata_id=19442002;Accessed 15.07.06
- Hu TW, Hsich CR. An Economic Analysis of Health Care Reform in Taiwan. Paper presented at the Menorial Oonference for Professor Kou-Shu-Shu Liang, Taipei, Taiwan, 1999.
- . The effects of outpatient co-payment policy on healthcare usage by the elderly in Taiwan. Arch Gerontol Geriatr. 2006;43:101–116
- Effects of cost-sharing in Taiwan, National Health Insurance System: some empirical results. Paper presented in Taipei International Conference on Health Economics. Academia Sinica, 1999.
- . Affordability of medicines and patients' cost-reducing behaviour: empirical evidence based on SUR estimates from Italy and the UK. Appl Health Econ Health Policy. 2005;4:23–35
- . Cost to the patient or cost to the healthcare system? Which one matters the most for GP prescribing decisions? A UK-Italy comparison. Eur J Public Health. 2003;13:18–23
- . Access to medicines: cost as an influence on the views and behaviour of patients. Health Soc Care Community. 2002;10:187–195
- . Coping with prescription charges in the UK. Int J Pharm Prac. 2004;12:239–246
- . Strategies used by general practitioners to minimise the impact of the prescription charge. Eur J Gen Pract. 2001;7:23–26
- . How did dentists respond to the introduction of global budgets in Taiwan? An evaluation using individual panel data. Int J Health Care Finance Econ. 2004;4:307–326
- . Application of concentration ratios to analyze the phenomenon of “next-door” pharmacy in Taiwan. Clin Ther. 2006;28:1225–1230
- . Impact of separating drug prescribing and dispensing on provider behaviour: Taiwan's experience. Health Policy Plan. 2003;18:316–329
- . Analysis of interrupted time series mortality trends: an example to evaluate regionalized perinatal care. Am J Public Health. 1981;71:38–46
- . Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002;27:299–309
- . Impacts of cost containment strategies on pharmaceutical expenditures of the national health insurance in Taiwan, 1996-2003. Pharmacoeconomics. 2006;24:891–902
- . Analysis of time series with calendar effects. Manag Sci. 1980;26:106–112
- . Effects of a prior-authorization policy for celecoxib on medical service and prescription drug use in a managed care Medicaid population. Clin Ther. 2004;26:1518–1532
- . Use of automated databases for pharmacoepidemiology research. Epidemiol Rev. 1990;12:87–107
- . The impacts of smart cards on hospital information systems—an investigation of the first phase of the national health insurance smart card project in Taiwan. Int J Med Inf. 2006;75:173–181
- . Effect of limiting Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia. N Engl J Med. 1994;331:650–655
- . Ability to pay and the decision to medicate. Med Care. 1998;36:202–211
- . Effects of user charges on the use of prescription medicines in different socio-economic groups. Health Policy. 1998;44:123–134
- . The cost of prescription medicines to patients. Health Policy. 2000;52:129–145
PII: S1551-7411(08)00089-2
doi: 10.1016/j.sapharm.2008.08.003
© 2009 Elsevier Inc. All rights reserved.
« Previous
Next »
Research in Social and Administrative Pharmacy
Volume 5, Issue 3
, Pages 211-224
, September 2009
